Skip to main content

Advertisement

SpringerLink
Log in

Comment on: “Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen”

  • Correspondence
  • Published:
Eye Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cozzi M, Monteduro D, Esposito RA, Spooner K, Fraser-Bell S, Staurenghi G, et al. Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen. Eye. 2024;38:161–7.

    Article  CAS  PubMed  Google Scholar 

  2. Veritti D, Sarao V, Soppelsa V, Danese C, Chhablani J, Lanzetta P. Managing neovascular age-related macular degeneration in clinical practice: systematic review, meta-analysis, and meta-regression. J Clin Med. 2022;11:325.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Frades I, Matthiesen R. Overview on techniques in cluster analysis. Bioinform Methods Clin Res. 2010;593:81–107.

    Article  CAS  Google Scholar 

  4. Mauschitz MM, Finger RP. Age-related macular degeneration and cardiovascular diseases: revisiting the common soil theory. Asia Pac J Ophthalmol. 2022;11:94–9.

    Article  CAS  Google Scholar 

  5. Keenan TD, Agrón E, Mares J, Clemons TE, van Asten F, Swaroop A, et al. Agerelated eye disease studies (AREDS) 1 and 2 research groups. adherence to the mediterranean diet and progression to late age-related macular degeneration in the age-related eye disease studies 1 and 2. Ophthalmology. 2020;127:1515–28.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Grupo de investigación en Visión y Salud Ocular (VISOC), Hospital Universitario del Valle, Universidad del Valle, Cali, Colombia

    Andrés Felipe Niño-Joya, Alexander M. Martínez-Blanco, Omar Salamanca & Francisco J. Bonilla-Escobar

  2. Oftalmosanitas Cali S.A.S., Cali, Colombia

    Andrés Felipe Niño-Joya & Alexander M. Martínez-Blanco

  3. Orbis International, New York, NY, USA

    Omar Salamanca

  4. Department of Ophthalmology, University of Washington, Seattle, WA, USA

    Francisco J. Bonilla-Escobar

  5. Fundación Somos Ciencia al Servicio de la Comunidad, Fundación SCISCO/Science to Serve the Community Foundation, SCISCO Foundation, Cali, Colombia

    Francisco J. Bonilla-Escobar

Authors
  1. Andrés Felipe Niño-Joya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander M. Martínez-Blanco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Omar Salamanca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francisco J. Bonilla-Escobar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Concept, writing, editing, and approval of the final version of the manuscript: AFNJ, AMMB, OS, FJBE.

Corresponding author

Correspondence to Andrés Felipe Niño-Joya.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Niño-Joya, A.F., Martínez-Blanco, A.M., Salamanca, O. et al. Comment on: “Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen”. Eye (2024). https://doi.org/10.1038/s41433-024-03063-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41433-024-03063-8

  • Springer Nature Limited

Search

Navigation